Search
Română
Magyar
English
Français
Deutsch
Italiano
Español
Русский
日本語
中国人
Change Language
Română
Magyar
English
Français
Deutsch
Italiano
Español
Русский
日本語
中国人
Sections
News
Exclusive
INSCOP Surveys
Podcast
EU
Diaspora
Republic of Moldova
Politics
Economy
Current Affairs
International
Sport
Health
Education
IT&C knowledge
Arts & Lifestyle
Opinions
Elections 2025
Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
News
Exclusive
INSCOP Surveys
Podcast
EU
Diaspora
Republic of Moldova
Politics
Economy
Current Affairs
International
Sport
Health
Education
IT&C knowledge
Arts & Lifestyle
Opinions
Elections 2025
Environment
13 events about "nuovo nordisk"
25 May 2026, 15:22
The European Medicines Agency has recommended the approval of the Wegovy tablet, a weight loss medication from Novo Nordisk.
International
18 February 2026, 08:17
The European Commission has approved the 7.2 mg dose of the medication Wegovy, which can support a more pronounced weight loss.
International
4 February 2026, 12:22
Novo Nordisk's earnings fell by 20% following warnings about price pressures in 2026
International
24 December 2025, 07:25
Novo Nordisk's shares rose by 9.2% after the Danish company became the first to receive FDA approval for the GLP-1 pill Wegovy, intended for weight loss.
International
23 December 2025, 08:52
The U.S. Food and Drug Administration (FDA) has approved the weight loss pill Wegovy, developed by Novo Nordisk.
Health
25 November 2025, 04:46
Novo Nordisk has announced that the study for semaglutide in the treatment of Alzheimer did not meet its objectives, causing a 10% drop in shares.
Economy
15 November 2025, 04:32
European stocks closed lower on Friday, affected by fears of a speculative bubble in AI and the weakness of the global economy.
Economy
9 November 2025, 06:25
Pfizer won the auction for the acquisition of Metsera, with a bid of 10 billion dollars, thus ending the competition with Novo Nordisk.
International
4 November 2025, 06:17
Pfizer has sued Novo Nordisk, accusing it of anti-competitive practices in an attempt to take over Metsera, a potential competitor in the obesity treatment market.
Health
22 October 2025, 05:51
Crisis at the peak of Novo Nordisk, at one point the most valuable European company. The president and several independent directors resign after a conflict with the majority shareholder.
International
10 September 2025, 09:28
The pharmaceutical giant Novo Nordisk announced the availability of 9,000 employees, equivalent to 11.5% of its workforce.
International
30 July 2025, 07:57
Novo Nordisk has appointed a new CEO, Maziar Mike Doustdar, and revised its financial estimates for 2023, forecasting a decline in sales.
Economy
16 October 2024, 09:14
The Novo Nordisk company is stopping the production of human insulin pen-type insulin syringes, affecting people with type 1 diabetes.
Health
Editor’s Recommendations
INSCOP Surveys
7 hours ago
November 2026: Informat.ro – INSCOP Research BAROMETER, 15th Edition – Chapter XI: Surveillance Cameras
Current Affairs
1 hour ago
The administrative reform prepared by the Government: local taxes cut in half for five years and 4 billion lei for localities that choose to merge
Current Affairs
4 hours ago
Raed Arafat, sent to trial over allegations concerning the customs regime in the helicopter case for SMURD
Exclusive
6 hours ago
EXCLUSIVE | Romania, as viewed by the Russian press / The scenario of unification with the Republic of Moldova, described as a “capitulation” of Chișinău
International
1 hour ago
The EU and the United Kingdom reached an agreement in Brussels, in a tentative step toward post-Brexit rapprochement / Where the two sides have differing opinions
Opinions
1 hour ago
Andrei Cornea: Politics, Ethics and Fanaticism
Opinions
8 hours ago
Editorials and opinions
Electoral dynamics
Exclusive
7 hours ago
EXCLUSIV E-TRENDS by NewsVibe. Top trending economic topics over the past week
Personalized news feed, AI-powered search, and notifications in a more interactive experience.